These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6778942)

  • 1. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
    Brown JE; Carton CL; Hougie C
    J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE; Thuy LP; Carton CL; Hougie C
    J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to human procoagulant factor VIII.
    Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
    J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein.
    Croissant MP; Zuzel M; Allain JP
    Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII.
    Croissant MP; van de Pol H; Lee HH; Allain JP
    Thromb Haemost; 1986 Dec; 56(3):271-6. PubMed ID: 2436329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of factor VIII antigen in hemophilic plasmas with human antibodies to factor VIII.
    Zimmerman TS; de la Pointe L; Edgington TS
    J Clin Invest; 1977 May; 59(5):984-9. PubMed ID: 853128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical patterns of hemophilic patients who develop inhibitors.
    McMillan CW
    Prog Clin Biol Res; 1984; 150():31-44. PubMed ID: 6431436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the stability of factor VIII coagulant antigen (VIII:CAg) in the presence of VIII:C antibodies.
    Furlong RA; Peake IR
    Br J Haematol; 1983 Jan; 53(1):55-63. PubMed ID: 6401211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoradiometric assay of factor VIII: coagulant antigen using four human antibodies. Study of 27 cases of haemophilia A.
    Girma JP; Lavergne JM; Meyer D; Larrieu MJ
    Br J Haematol; 1981 Feb; 47(2):269-82. PubMed ID: 6781526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of monoclonal antibodies to factor VIII:C.
    Nordfang O; Ezban M; Favaloro JM; Dahl HH; Hansen JJ
    Thromb Haemost; 1985 Oct; 54(3):586-90. PubMed ID: 2418524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
    Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
    Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAg.
    Nordfang O; Ezban M; Dinesen B
    Thromb Haemost; 1985 Jun; 53(3):346-50. PubMed ID: 3931283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
    Allain JP; Gaillandre A; Lee H
    J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.
    Singer ST; Addiego JE; Reason DC; Lucas AH
    Thromb Haemost; 1996 Jul; 76(1):17-22. PubMed ID: 8819245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII coagulant antigen in hemophilic plasma: a comparison of five alloantibodies.
    Reisner HM; Price WA; Blatt PM; Barrow ES; Graham JB
    Blood; 1980 Oct; 56(4):615-19. PubMed ID: 6774789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.
    Ewenstein BM; Hoots WK; Lusher JM; DiMichele D; White GC; Adelman B; Nadeau K
    Haematologica; 2000 Oct; 85(10 Suppl):35-9. PubMed ID: 11187868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme linked immunosorbent assay (ELISA) for the measurement of factor VIII coagulant antigen (CAg) using haemophilic antibodies.
    Ingerslev J; Stenbjerg S
    Br J Haematol; 1986 Feb; 62(2):325-32. PubMed ID: 3081021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.